Net shares · 30d
-40.5K
0 buy · 40.5K sell
Net value · 30d
-$2.9M
$0 in · $2.9M out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
3
0 buy · 40.5K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 30d
-
ORKA Sell·S
Director · 10b5-1
$2.5M
35.0K sh · $70.13 avg · 2 lots
Own -47%
-
APGE Sell·S
Chief Medical Officer · 10b5-1
$432.9K
5.5K sh · $78.71
Own -3%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | ORKA | Sell S | 35.0K2 lots | $2.5M |
| Jun 3, 2026 | APGE | Sell S | 5.5K | $432.9K |
Buy Sell Non-market (grant · exercise · gift)
About Dambkowski Carl
This profile aggregates every SEC Form 4 insider transaction reported by Dambkowski Carl across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.